Albemarle (NYSE: ALB) director Laurie Brlas receives new stock awards

Rhea-AI Filing Summary

ALBEMARLE CORP director Laurie Brlas reported equity awards of common stock as part of non-employee director compensation. On July 1, 2026, Brlas received two acquisitions of common stock valued at $0.00 per share, reflecting stock-based compensation rather than open-market purchases.

The filing shows an award of 1,250 shares of common stock as an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation, scheduled to vest on July 1, 2027. It also shows 36 shares issued for dividends accrued on a prior award granted on July 1, 2025 that vested in full on July 1, 2026, which the company elected to settle in stock under the same plan.

After these awards, Brlas holds 7,289 shares of Albemarle common stock directly and 6,900 shares indirectly through a spouse, according to the filing.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider BRLAS LAURIE

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,250	$0.00	--
Grant/Award	Common Stock	36	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,253 shares (Direct, null); Common Stock — 6,900 shares (Indirect, By Spouse)

Footnotes (1)

1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027. Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Key Figures

Annual director stock award: 1,250 shares Dividend share issuance: 36 shares Award price: $0.00 per share +2 more

5 metrics

Annual director stock award 1,250 shares Common Stock grant under 2023 Directors Plan, vests July 1, 2027

Dividend share issuance 36 shares Dividends accrued on award granted July 1, 2025, vested July 1, 2026

Award price $0.00 per share Reported transaction price for both stock compensation entries

Direct holdings after awards 7,289 shares Total Albemarle common stock held directly by Brlas after transactions

Indirect holdings via spouse 6,900 shares Common stock held indirectly by spouse as of the Form 4

Key Terms

2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation, non-employee director stock compensation, dividends accrued, vest in full

4 terms

2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation financial

"pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation"

non-employee director stock compensation financial

"Shares represent an annual installment of non-employee director stock compensation"

dividends accrued financial

"Represents dividends accrued on shares underlying an award granted on July 1, 2025"

vest in full financial

"award granted on July 1, 2025, that vested in full on July 1, 2026"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 05:29 PM Accepted by SEC EDGAR 07/06/2026 - 05:29 PM Learn about SEC filing dates

FAQ

What did Albemarle (ALB) director Laurie Brlas report in this Form 4?

Laurie Brlas reported stock-based compensation awards of Albemarle common stock. The filing shows two acquisitions under the 2023 Directors Plan and updated direct and indirect share holdings following these compensation-related transactions.

How many Albemarle (ALB) shares did Laurie Brlas acquire in the latest awards?

Laurie Brlas acquired 1,250 shares as an annual non-employee director stock award and 36 additional shares from accrued dividends. Both were granted at $0.00 per share as equity compensation under Albemarle’s 2023 Directors Plan.

What is the vesting schedule for Laurie Brlas’s new Albemarle (ALB) stock award?

The 1,250-share award to Laurie Brlas is scheduled to vest on July 1, 2027. It represents an annual installment of non-employee director stock compensation under Albemarle’s 2023 Stock Compensation and Deferral Election Plan.

Why did Albemarle (ALB) issue 36 shares to Laurie Brlas in this Form 4?

The 36 shares represent dividends accrued on a prior award granted July 1, 2025, that vested July 1, 2026. Albemarle elected to settle those accrued dividends in shares of common stock under its 2023 Directors Plan.

How many Albemarle (ALB) shares does Laurie Brlas hold after these transactions?

Following the reported awards, Laurie Brlas holds 7,289 Albemarle common shares directly. The filing also notes 6,900 additional shares held indirectly through a spouse, reflecting combined direct and indirect ownership positions.

Are Laurie Brlas’s Albemarle (ALB) Form 4 transactions open-market purchases or compensation?

The Form 4 transactions are compensation-related equity awards, not open-market purchases. Both acquisitions were reported at a price of $0.00 per share and are described as non-employee director stock compensation under Albemarle’s 2023 Directors Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRLAS LAURIE

(Last) (First) (Middle)

ALBEMARLE CORPORATION

4250 CONGRESS STREET # 900

(Street)

CHARLOTTE NORTH CAROLINA 28209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		1,250(1)	A	$0	7,253	D
Common Stock	07/01/2026		A		36(2)	A	$0	7,289	D
Common Stock								6,900	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

2. Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)